▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

NortonLifeLock Q4 22 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 5/5/2022 3:00 PM ET

NortonLifeLock Inc. (NLOK) will host a conference call at 5:00 PM ET on May 5, 2022, to discuss Q4 22 earnings results.

To access the live webcast, log on to https://investor.nortonlifelock.com/About/Investors/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In December 2022

Latest Updates on COVID-19

Covid-19 Remains An International Emergency: WHO

U.S. Covid Metrics Signal Ease In Pandemic

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

US Covid Deaths Rise By 78% In 2 Weeks

78% Increase In US Covid Deaths In A Fortnight

Read More

COVID-19: Drugs in Development

Follow RTT

Editor's Pick
Most Read
Most Emailed

Exxon Mobil Q4 Results Top Estimates

Daiso Recalls Matsunaga Mini Shiruko Sand Biscuits

Court Rejects J&J Bankruptcy Petition To End Talc Cancer Lawsuits

Frozen, Fully Cooked Jambalaya And Gumbo Products Recalled

GE HealthCare Q4 Profit Declines

Toyota Is World's Top-selling Automaker Again

Rao's Slow Simmered Soup, Chicken & Gnocchi Recalled

Daniele Intl Recalls Ready-to-Eat Sausage Products

Chevron Q4 Profit Up 25%, But Misses Estimates

ZLINE Expands Recall Of Gas Ranges

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Drizzilicious Mini Rice Cake Bites, Popcorn Recalled

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Biotech Stocks Facing FDA Decision In February 2023

Syros Gets Fast Track Designation In U.S. For Tamibarotene For Myelodysplastic Syndrome Treatment

Sartorius Stedim Biotech FY22 Profit Rises, Orders Down; Sees Growth In FY23; Raises FY25 Sales View

Evotec Partners With Janssen Biotech To Develop Immune-based Cancer Therapies

Resmed Inc Q2 Profit Increases, beats estimates

Sartorius FY22 Prelim Earnings, Revenue Rise

Merck's KEYTRUDA Gets FDA Approval To Treat Stage IB, II, IIIA Non-small Cell Lung Cancer Patients

Regeneron Pharma: CHMP Adopts Positive Opinion For Dupixent

Eisai : EMA Accepts MAA For Lecanemab As Treatment For Early Alzheimer's Disease

Ipsen: CHMP Recommends Not To Grant Marketing Authorization For Palovarotene As Treatment For FOP

Lucid Group Opens First Retail Studio And Service Centre In Quebec

Toyota Is World's Top-selling Automaker Again

TFS FINANCIAL CORP. Q1 income increases in line with estimates

Playtech Plc Projects FY22 Adj. EBITDA To Rise 26%

Eastern Bankshares Down 11% As Q4 Earnings Fell Shy Of Estimates

Philip Morris Int'l To Commercialize KT&G's Smoke-Free Products Outside South Korea

Corning Q4 Profit Tops Estimates; Issues Q1 Guidance

Ipsen: CHMP Recommends Not To Grant Marketing Authorization For Palovarotene As Treatment For FOP

Archer-Daniels-Midland Q4 Profit Increases, beats estimates

CNX Resources Corporation Q4 Income Climbs

Eisai : EMA Accepts MAA For Lecanemab As Treatment For Early Alzheimer's Disease

Syros Gets Fast Track Designation In U.S. For Tamibarotene For Myelodysplastic Syndrome Treatment

M.D.C. Holdings Q4 Net Income Declines; Home Sale Revenues Up 4%